Graveno ME, Carulli A, Freyer CW, Mangan BL, et al. Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia. Leuk Lymphoma 2022 Mar 8:1-6. doi: 10.1080/10428194.2022.2042688.
PMID: 35259056